In February 2004, pemetrexed disodium (Alimta; Eli Lilly), an anticancer drug that targets folate-dependent reactions that are essential for cell proliferation, became the first drug to be ...

Eli Lilly ended 2019 with a win in its long-running legal battle to prevent generics of its big-selling cancer drug Alimta from reaching the US market. The ruling came in a dispute with Canadian ...

Shares in Mylan have risen after the FDA gave a tentative approval to its generic version of Eli Lilly’s blockbuster cancer therapy Alimta. The preliminary approval clears the way for Mylan to ...